title: Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dutch Society of Dermatology and Venereology.
abstract: This document provides a summary of the Dutch S3-guidelines on the treatment of psoriasis. These guidelines were finalized in December 2011 and contain unique chapters on the treatment of psoriasis of the face and flexures, childhood psoriasis as well as the patient's perspective on treatment. They also cover the topical treatment of psoriasis, photo(chemo)therapy, conventional systemic therapy and biological therapy.
authors.affiliation: Dutch Society of Dermatology and Venereology. j.zweegers@derma.umcn.nl.
authors.forename: J
authors.initials: J
authors.lastname: Zweegers
authors.forename: E M G J
authors.initials: EM
authors.lastname: de Jong
authors.forename: T E C
authors.initials: TE
authors.lastname: Nijsten
authors.forename: J
authors.initials: J
authors.lastname: de Bes
authors.forename: M
authors.initials: M
authors.lastname: te Booij
authors.forename: R J
authors.initials: RJ
authors.lastname: Borgonjen
authors.forename: O D
authors.initials: OD
authors.lastname: van Cranenburgh
authors.forename: H
authors.initials: H
authors.lastname: van Deutekom
authors.forename: J J E
authors.initials: JJ
authors.lastname: van Everdingen
authors.forename: M
authors.initials: M
authors.lastname: de Groot
authors.forename: C L M
authors.initials: CL
authors.lastname: Van Hees
authors.forename: H
authors.initials: H
authors.lastname: Hulshuizen
authors.forename: M B G
authors.initials: MB
authors.lastname: Koek
authors.forename: W J A
authors.initials: WJ
authors.lastname: de Korte
authors.forename: J
authors.initials: J
authors.lastname: de Korte
authors.forename: L L A
authors.initials: LL
authors.lastname: Lecluse
authors.forename: M C
authors.initials: MC
authors.lastname: Pasch
authors.forename: P A
authors.initials: PA
authors.lastname: Poblete-Gutiérrez
authors.forename: E P
authors.initials: EP
authors.lastname: Prens
authors.forename: M M B
authors.initials: MM
authors.lastname: Seyger
authors.forename: H B
authors.initials: HB
authors.lastname: Thio
authors.forename: L A
authors.initials: LA
authors.lastname: Torcque
authors.forename: A C Q
authors.initials: AC
authors.lastname: de Vries
authors.forename: P C M
authors.initials: PC
authors.lastname: van de Kerkhof
authors.forename: Ph I
authors.initials: PI
authors.lastname: Spuls
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D000075202:Contraindications; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009426:Netherlands; D010342:Patient Acceptance of Health Care; D011565:Psoriasis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012176:Retinoids / Q000627:therapeutic use; D014467:Ultraviolet Therapy / Q000009:adverse effects / Q000191:economics
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D001688:Biological Products; D007166:Immunosuppressive Agents; D012176:Retinoids